Routine assessment of HRQoL using an ePROM platform was feasible, acceptable, and usable for children aged 5-12 years with cancer. Preliminary evidence suggesting clinical utility supports the need for future implementation-effectiveness studies.
Doig et al. (Sun,) studied this question.